BIOQUAL, Inc. Announces New CFO

Rhea-AI Summary

BIOQUAL, Inc. has announced the promotion of Charles (Chris) C. Kirk, Jr. to Chief Financial Officer. With over 25 years of experience in finance and accounting, Mr. Kirk previously served as Director of Finance and Accounting at BIOQUAL. He will lead the company’s Accounting/Finance team and join the executive leadership. The press release also highlights potential risks and uncertainties affecting the company’s operations, such as contract extensions, demand for animal models, and financial management.

Positive

• Charles C. Kirk's extensive experience in finance could enhance financial leadership.
• Promotion may indicate confidence in Mr. Kirk's ability to manage company finances effectively.

Negative

• Risks related to extending government contracts may impact revenue stability.
• Dependence on third parties could affect operational efficiency.
• Uncertainties in demand for animal models may jeopardize future growth.

ROCKVILLE, Md.--(BUSINESS WIRE)-- BIOQUAL, Inc., Announces Promotion of Mr. Charles (Chris) C. Kirk, Jr., CPA. to the Position of Chief Financial Officer. Mr. Kirk has over 25 years of experience in leadership roles in finance and accounting departments for both Government contracting and services-oriented companies as well as in the public accounting sector. Mr. Kirk has served as Director of Finance and Accounting for BIOQUAL over the past year and has a degree in Accounting/Finance from the University of Maryland.

In his role as Chief Financial Officer, Mr. Kirk will lead the Accounting/Finance team at BIOQUAL and will join the company’s executive leadership team.

Forward Looking Information

Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. The forward-looking statements are neither promises nor guarantees, and one should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond the Company’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including risks relating to the ability to continue to extend current government contracts; the Company’s ability to obtain new government or commercial contracts; continued demand for the use of animal models in scientific research; the Company’s ability to obtain sufficient numbers of animal models; the availability of adequate numbers of employees; the Company’s ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company’s contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221005005736/en/

Mark G. Lewis, Ph.D., CEO (240-404-7654)

www.bioqual.com

Source: BIOQUAL, Inc.

FAQ

Who is the new CFO of BIOQUAL?

Charles (Chris) C. Kirk, Jr. has been promoted to Chief Financial Officer.

What experience does Chris Kirk have?

Chris Kirk has over 25 years of experience in finance, including leadership roles in government contracting and public accounting.

What are the risks mentioned in BIOQUAL's press release?

Risks include contract renewals, demand for animal models, and reliance on third parties.

When was the announcement made regarding the CFO promotion?

The announcement was made on October 5, 2022.

What is the stock symbol for BIOQUAL?

The stock symbol for BIOQUAL is BIOQ.